A randomized , double-blind trial was conducted in @ obese , unmedicated individuals with metabolic syndrome ( mean age @ @ y , body mass index @ @ kg/m ( @ ) ) who received @ weeks of pioglitazone ( PIO ; @ mg for @ wk , then @ mg daily ) or matched placebo .